Status:

COMPLETED

Host Response to Urinary Tract Infection in Women

Lead Sponsor:

University of Washington

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Urinary Tract Infection

Eligibility:

FEMALE

18-49 years

Brief Summary

This study is being done to identify those elements of the immune response that may predispose a woman to recurrent urinary tract infection. We suspect that lesser effectiveness of certain components ...

Detailed Description

Procedures subjects will undergo once they have read and signed the consent are: Questions about their medical and sexual history and current symptoms of urinary tract infection. They will be asked t...

Eligibility Criteria

Inclusion

  • Female
  • Age 18-49 years
  • Able to provide written informed consent
  • diagnosis of acute cystitis with symptoms for fewer than 7 days

Exclusion

  • Not pregnant or planning pregnancy in next 3 months
  • No chronic illness requiring medical supervision (e.g. diabetes mellitus)
  • No known anatomic or functional abnormalities of the urinary tract
  • No signs or symptoms suggestive of pyelonephritis (flank pain or tenderness, temperature over 100 degrees F, nausea or vomiting)

Key Trial Info

Start Date :

February 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2012

Estimated Enrollment :

326 Patients enrolled

Trial Details

Trial ID

NCT00642070

Start Date

February 1 2008

End Date

July 1 2012

Last Update

June 5 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Washington/Hall Health Primary Care Center

Seattle, Washington, United States, 98195